Quarter Financials
Adamas Pharmaceuticals, Inc. (ADMS)
$8.22
0.00 (0.00%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
2020 Q2
|
2020 Q1
|
2019 Q4
|
|---|
| Net Income | -20 | -12 | -13 | -18 | -12 | -11 | -17 | -23 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -550 | -530 | -518 | -505 | -487 | -475 | -465 | -448 |
|---|
|
Year
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
2020 Q2
|
2020 Q1
|
2019 Q4
|
|---|
| Capital Expenditure | -0 | - | - | 0 | - | - | - | - |
|---|
| Net PPE | 7 | 7 | 8 | 8 | 9 | 9 | 10 | 10 |
|---|
|
Year
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
2020 Q2
|
2020 Q1
|
2019 Q4
|
|---|
| New Purchases | -37 | -34 | -30 | -5 | -37 | -3 | -27 | -3 |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|